CAPRIOLI, FLAVIO ANDREA
CAPRIOLI, FLAVIO ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus
2025 A. Dal Buono, A. Armuzzi, F. Caprioli, F. Castiglione, S. Danese, P. Gionchetti, D. Lazzari, S. Leone, A. Orlando, M. Vecchi
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study
2025 D. Noviello, M. Chaparro, C. Viganò, A. Blesl, B. Barberio, H. Yanai, A. Orlando, R. Ferreiro-Iglesias, C. Bezzio, A. Zilli, T. Molnár, C. Gheorghe, F. Conforti, T. Innocenti, S. Saibeni, P. Bossuyt, R. Oliveira, A.M. Carvalhas Gabrielli, A. Losco, S. Vieujean, E. Tettoni, L. Pirola, S. Calderone, M. Kornowski Cohen, G. Dragoni, T. Rath, M. Barreiro-de Acosta, E.V. Savarino, J.P. Gisbert, M. Vecchi, R. Atreya, F. Caprioli
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease
2024 C. Bezzio, G. Franchellucci, E.V. Savarino, M. Mastronardi, F.A. Caprioli, G. Bodini, A. Variola, F. Scaldaferri, F. Furfaro, E. Calabrese, M.B. Principi, G. Biscaglia, M. Marzo, A. Michielan, C. Cavalli, A. Aratari, M. Campigotto, L. Ceccarelli, M. Cappello, S. Saibeni, P. Balestrieri, A. Soriano, V. Casini, L. Bertani, B. Barberio, F.S. Conforti, S. Danese, A. Armuzzi
Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion
2024 A. Díaz-Basabe, G. Lattanzi, F. Perillo, C. Amoroso, A. Baeri, A. Farini, Y. Torrente, G. Penna, M. Rescigno, M. Ghidini, E. Cassinotti, L. Baldari, L. Boni, M. Vecchi, F. Caprioli, F. Facciotti, F. Strati
Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer
2024 G. Lattanzi, F. Perillo, A. Díaz-Basabe, B. Caridi, C. Amoroso, A. Baeri, E. Cirrincione, M. Ghidini, B. Galassi, E. Cassinotti, L. Baldari, L. Boni, M. Vecchi, F. Caprioli, F. Facciotti, F. Strati
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
2024 A.M. Carvalhas Gabrielli, F. Ferretti, C.M. Monico, E. Tombetti, G. Maconi, S. Romeo, N. Piazza O Sed, F. Caprioli, A.M. Mazzola, S. Alicante, R. Bertè, E. Lolli, M.L. Scribano, E. Buscarini, C. Ricci, S. Carmagnola, S. Ardizzone, R. Cannatelli
Management of Clostridioides difficile infection: an Italian Delphi consensus
2024 M. Bassetti, A. Cascio, F.G. De Rosa, M. Meschiari, R. Parrella, N. Petrosillo, A. Armuzzi, F. Caprioli, F. Dentali, M. Pani, A. Pilotto, U. Restelli, M. Sanguinetti
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)
2024 G. Bergamaschi, F. Castiglione, R. D'Incà, M. Astegiano, W. Fries, M. Milla, C. Ciacci, F. Rizzello, S. Saibeni, R. Ciccocioppo, A. Orlando, F. Bossa, M. Principi, P. Vernia, C. Ricci, M.L. Scribano, G. Bodini, D. Mazzucco, G. Bassotti, G. Riegler, A. Buda, M. Neri, F. Caprioli, F. Monica, A. Manca, E. Villa, G. Fiorino, N. Aronico, M.V. Lenti, C. Mengoli, A. Testa, M. Vecchi, C. Klersy, A. Di Sabatino
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
2024 L. Peyrin-Biroulet, J.C. Chapman, J. Colombel, F. Caprioli, G. D'Haens, M. Ferrante, S. Schreiber, R. Atreya, S. Danese, J.O. Lindsay, P. Bossuyt, B. Siegmund, P.M. Irving, R. Panaccione, Q. Cao, E. Neimark, K. Wallace, T. Anschutz, K. Kligys, W.R. Duan, V. Pivorunas, X. Huang, S. Berg, L. Shu, M. Dubinsky
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion
2024 G. Leccese, M. Chiara, I. Dusetti, D. Noviello, E. Billard, A. Bibi, G. Conte, C. Consolandi, M. Vecchi, M.P. Conte, N. Barnich, F. Caprioli, F. Facciotti, M. Paroni
Costo per Number Needed to Treat (NNT) di upadacitinib nel trattamento dei pazienti bio-exposed con rettocolite ulcerosa attiva da moderata a grave
2024 F. Caprioli, M.C. Fantini, F. Marando, D. Scaduto, R. Ravasio
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study
2024 G. Dragoni, T. Innocenti, A. Amiot, F. Castiglione, L. Melotti, S. Festa, E.V. Savarino, M. Truyens, K. Argyriou, D. Noviello, T. Molnar, V. Bouillon, C. Bezzio, P. Eder, S. Fernandes, A. Kagramanova, A. Armuzzi, R. Oliveira, A. Viola, D.G. Ribaldone, I. Drygiannakis, C. Viganò, F. Calella, A.G. Gravina, D. Pugliese, M. Chaparro, P. Ellul, S. Vieujean, M. Milla, F. Caprioli
The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn’s Disease in Italy: An IG-IBD Survey.
2024 T. Pessarelli, M. Topa, A. Sorge, N. Nandi, D. Pugliese, F. Salvatore Macaluso, A. Orlando, S. Saibeni, A. Costantino, F. Stalla, V. Zadro, L. Scaramella, M. Vecchi, F. Caprioli, L. Elli
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
2024 M. Allocca, G. Catalano, E.V. Savarino, M. Chaparro, A. Levartovsky, G. Michalopoulos, N. Viazis, F.S. Fousekis, A. Psistakis, D. Noviello, C.N.D. Nascimento, B. Caron, V. Kitsou, G. Bamias, M.J. García, E. Zacharopoulou, K. Foteinogiannopoulou, F. D'Amico, I. Koutroubakis, P. Ellul, M. Tzouvala, L. Peyrin-Biroulet, J. Torres, F. Caprioli, K. Karmiris, A. Theodoropoulou, K.H. Katsanos, D.K. Christodoulou, G.J. Mantzaris, U. Kopylov, J.P. Gisbert, S. Danese, F. Magro, F. Carla, G. Fiorino
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey
2024 F. Castiglione, L. Scarallo, O.M. Nardone, M. Aloi, P. Alvisi, A. Armuzzi, S. Arrigo, G. Bodini, E. Calabrese, L. Ceccarelli, W. Fries, A. Marseglia, M. Martinelli, M. Milla, A. Orlando, A. Rispo, F. Rizzello, C. Romano, F. Caprioli, P. Lionetti
Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus
2024 M. Claudio Fantini, G. Fiorino, A. Colli, D. Laharie, A. Armuzzi, F.A. Caprioli, J. P Gisbert, J. Kirchgesner, F. Salvatore Macaluso, F. Magro, S. Ghosh
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey
2024 M. Vernero, C. Bezzio, D.G. Ribaldone, F.A. Caprioli, M.C. Fantini, S. Festa, F.S. Macaluso, A. Orlando, D. Pugliese, S. Renna, A. Rispo, E.V. Savarino, A. Variola, S. Saibeni
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus
2024 S. Ardizzone, A. Armuzzi, F. Caprioli, F. Castiglione, S. Danese, M. Daperno, M.C. Fantini, W. Fries, M.B. Principi, E. Savarino, P. Gionchetti
Response to Wei-Zhen Tang et al
2024 G. Dragoni, T. Innocenti, F. Caprioli
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024 F.S. Macaluso, F. Caprioli, L. Benedan, C. Bezzio, R. Caporali, A. Cauli, M.S. Chimenti, F. Ciccia, S. D'Angelo, M.C. Fantini, S. Festa, F. Iannone, E. Lubrano, P. Mariani, C. Papi, G. Provenzano, D. Pugliese, A. Rispo, S. Saibeni, C. Salvarani, A. Variola, M. Zenga, A. Armuzzi, A. Orlando, R. Gerli